Zhenlin Jin
Role not yet determined Is this you? Add your title
Also affiliated: Wenzhou Medical University (2017–2022); First Affiliated Hospital of Wenzhou Medical University (2017–2022); Shanghai Cell Therapy Research Institute (2021)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Zhenlin Jin's research focuses on the molecular mechanisms underlying various diseases, particularly in oncology and hematology. Jin has investigated the role of long non-coding RNAs (lncRNAs) in cancer progression, such as DLX6-AS1 in hepatocellular carcinoma and LINC00460 in acute myeloid leukemia (AML). The work also explores the regulatory functions of microRNAs (miRNAs) in cellular processes, including their involvement in myeloid differentiation and AML, as seen with miR-10a/b. Additionally, Jin has been involved in clinical research, contributing to a Phase I trial for EGFR-specific CAR-T cells in non-small cell lung cancer. Other research areas include the potential therapeutic mechanisms of traditional Chinese medicine, like Huang-Lian-Jie-Du Decoction for rheumatoid arthritis, and the analysis of immune cell infiltration in gastric cancer to inform immunotherapy strategies. Jin's scholarship metrics include an h-index of 8 across 12 publications, with a total of 359 citations.
Metrics
- h-index: 8
- Publications: 12
- Citations: 359
Selected Publications
-
Analysis of Implementation Pathways for Generative AI in Cross-language Code Migration and Compatibility Testing (2025)
Similar Researchers
Based on overlapping research topics